Wize Pharma Fundamental Relationships

WIZP -- Israel Stock  

ILS 213.00  10.20  5.03%

The Drivers Module shows relationships between Wize Pharma's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Wize Pharma over time as well as its relative position and ranking within its peers. See also Your Current Watchlist.

Wize Pharma Total Debt vs. Cash per Share Fundamental Analysis

Wize Pharma is rated fourth in cash per share category among related companies. It is rated fourth in total debt category among related companies making up about  35,350,000  of Total Debt per Cash per Share.
Cash per Share is a ratio of current cash on hands or in the banks of the company to total number of shares outstanding. It is used to determine firm's liquidity and is a good indicator of overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Wize Pharma 
Cash per Share 
Total Cash 
Average Shares 
Companies with high Cash per Share ratio will be considered as attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principle payments will eventually prevent the firm from borrow excessively.
Wize Pharma 
Total Debt 
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
      Wize Pharma Comparables 
Wize Pharma is currently under evaluation in revenue category among related companies.
Search macroaxis.com